Abstract:Ulcerative colitis is a kind of inflammatory bowel disease that is easy to recur and difficult to cure, and no special drug with low side effects has been found to treat this disease, which poses a great threat to the intestinal health of humans. Bovine lactoferrin is derived mainly from bovine milk. LfcinB is a small molecular peptide obtained by hydrolysis of bovine lactoferrin in the digestive tract of animals. It has strong antibacterial and anti-inflammatory activities. However, direct evidence that LfcinB improves the efficacy of colitis in mice is rarely reported. In this study, the protective effect and preliminary mechanism of LfcinB in colitis mice were evaluated, and the morphology of the colonic epithelium was observed by H & E staining. The TUNEL method and immunohistochemistry were used to detect the apoptosis index of colonic epithelial cells and the infiltration of inflammatory cells. The distribution of goblet cells was analyzed by the AB-PAS method. The expression level of the tight junction protein ZO-1 was analyzed by immunofluorescence. Western blot was used to detect the expression levels of three tight junction proteins ZO-1, claudin-1, and occludin in colon tissue and the activation level of the inflammatory pathway. 16SrRNA analysis was used to detect the microbial composition in the cecum. The results showed that the intestinal epithelial morphology of DSS treated mice was destroyed, the apoptosis index of colonic epithelial cells and the infiltration index of inflammatory cells were also significantly increased, the number of goblet cells was significantly reduced, the expression and distribution of tight junction proteins was also significantly reduced, NF-κB and MAPK signaling pathways were activated and the composition of intestinal microorganisms was imbalanced. LfcinB intervention significantly improved these conditions. In summary, LfcinB alleviates DSS-induced ulcerative colitis by reducing intestinal barrier damage, inhibiting the activation of inflammatory pathways, and improving intestinal microbial composition in colitis mice, and has a good protective effect on the intestinal tract.

A case of transposition of the great arteries in adult

Amelioration of Dextran Sulfate Sodium-Induced Experimental Ulcer Colitis in Mice by Bacillus licheniformis

[Meaning of healthy living for health users, professionals and managers].

Lactiplantibacillus plantarum ZJ316-fermented milk ameliorates dextran sulfate sodium-induced chronic colitis by improving the inflammatory response and regulating intestinal microbiota

Prevention and Alleviation of Dextran Sulfate Sodium Salt-Induced Inflammatory Bowel Disease in Mice With Bacillus subtilis-Fermented Milk via Inhibition of the Inflammatory Responses and Regulation of the Intestinal Flora

Fermented Soymilk with Probiotic Lactobacilli and Bifidobacterium Strains Ameliorates Dextran-Sulfate-Sodium-Induced Colitis in Rats

[The history of dandruff and dandruff in history. A homage to Raymond Sabouraud].

Orally Administered Lactobacillus rhamnosus CY12 Alleviates DSS-Induced Colitis in Mice by Restoring the Intestinal Barrier and Inhibiting the TLR4-MyD88-NF-κB Pathway via Intestinal Microbiota Modulation

Zeolite-containing Mixture Alleviates Microbial Dysbiosis in Dextran Sodium Sulfate-Induced Colitis in Mice

Alleviation Effects of Bifidobacterium animalis subsp. lactis XLTG11 on Dextran Sulfate Sodium-Induced Colitis in Mice

A Mixture of Lactobacillus fermentum HFY06 and Arabinoxylan Ameliorates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice

Different Effects of Different Lactobacillus acidophilus Strains on DSS-Induced Colitis

Protective effect of Limosilactobacillus fermentum HFY06 on dextran sulfate sodium-induced colitis in mice

Oral administration of LfcinB alleviates DSS-induced colitis by improving the intestinal barrier and microbiota

Lactobacillus rhamnosus KBL2290 Ameliorates Gut Inflammation in a Mouse Model of Dextran Sulfate Sodium-Induced Colitis

Probiotic and Rice-Derived Compound Combination Mitigates Colitis Severity

The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice

Fermented milk containing Lactobacillus GG alleviated DSS-induced colitis in mice and activated epidermal growth factor receptor and Akt signaling in intestinal epithelial cells

Lactobacillus casei ATCC 393 and it's metabolites alleviate dextran sulphate sodium-induced ulcerative colitis in mice through the NLRP3-(Caspase-1)/IL-1β pathway

Oral delivery of a Lactococcus lactis strain secreting bovine lactoferricin–lactoferrampin alleviates the development of acute colitis in mice

Mycophenolate mofetil for severe autoimmune haemolytic anemia